Hold deg oppdatert
Få relevant informasjon om blant annet:
- Medisinske nyheter
- Webinarer
- Pasientstøtte
- Produktinformasjon
- Bivirkningsrapportering
Du kan når som helst trekke tilbake ditt samtykke.
Approval ID: NO-13159-10-24-CVRM
Referanser:
1. National Kidney Foundation, June 2023;
2. NHI https://nhi.no/sykdommer/hormoner-og-naring/diverse/hyperkalemi
Approval ID: NO-13159-10-24-CVRM
Referanser:
3. Hunter.RW, Bailey.M.A, Nephrology Dialysis Transplantation, December 2019, Pages iii2–iii11, https://doi.org/10.1093/ndt/gfz206
Approval ID: NO-13159-10-24-CVRM
Referanser:
1. National Kidney Foundation, June 2023;
2. NHI https://nhi.no/sykdommer/hormoner-og-naring/diverse/hyperkalemi
Approval ID: NO-13159-10-24-CVRM
Referanser:
4. KDIGO 2024 Clinical Practice Guideline for Evaluation and management of CKD, KDIGO CKD Work Group, Kindney Int. 2024;105(suppl 4S):S117-S314
5. 2021 ESC Guidelines for the Diagnosis and Treatment og Acute and Chronic HF, Theresa A McDonagh, Marco Metra, et al. Article and supplementary data Eur heart J 2021:42(36):3599-3726;6. 2023 ESH Guidelines for the Management of Arterial Hypertension, Giuseppe Mancia, Reinhold
Approval ID: NO-13159-10-24-CVRM
Referanser:
7. Stefania Paolillo, Christian Basile, et al, Eur J Intern Med, 2024 Jan:119:109-117; b. Anjay Rastogi, Charles V Pollack, et al, Clin Kidney J. 2024 Mar 25;17(5).
Få relevant informasjon om blant annet:
Du kan når som helst trekke tilbake ditt samtykke.